U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07351825) titled 'CMR Prognostic Markers in Ischemic Heart Disease' on Dec. 29, 2025.
Brief Summary: Ischemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide. Accurate risk stratification is essential for guiding clinical management and improving long-term outcomes in patients with ischemic myocardial injury.
Cardiovascular magnetic resonance (CMR) imaging provides comprehensive assessment of myocardial structure, function, and tissue characteristics, enabling detailed evaluation of ischemic injury and its consequences.
This multicenter, retrospective observational study aims to investigate the prognostic value of m...